0

Rhythm Disorders and Devices Collection
 1-20 of 43 Articles
ACP Journal Club |  15 April 2014
Review: Dabigatran does not differ from vitamin K antagonists for mortality or major bleeding
Alex Gallus, MB, FRACP, FRCPA
Ann Intern Med. 2014;160(8):JC5. doi:10.7326/0003-4819-160-8-201404150-02005
ACP Journal Club |  18 March 2014
In overweight or obese patients with atrial fibrillation, a weight reduction program reduced symptoms
D. George Wyse, MD, PhD, FACP
Ann Intern Med. 2014;160(6):JC6. doi:10.7326/0003-4819-160-6-201403180-02006
ACP Journal Club |  18 March 2014
Edoxaban was noninferior to warfarin for preventing stroke or systemic embolism in atrial fibrillation
Stacy A. Johnson, MD; Matthew T. Rondina, MD
Ann Intern Med. 2014;160(6):JC7. doi:10.7326/0003-4819-160-6-201403180-02007
ACP Journal Club |  18 March 2014
Warfarin dosing by genotype did not improve time in therapeutic range
Andrew Dunn, MD, MPH, SFHM, FACP
Ann Intern Med. 2014;160(6):JC8. doi:10.7326/0003-4819-160-6-201403180-02008
ACP Journal Club |  18 March 2014
In AF or VTE, warfarin dosing by genotype improved time in therapeutic range but not clinical outcomes
Andrew Dunn, MD, MPH, SFHM, FACP
Ann Intern Med. 2014;160(6):JC9. doi:10.7326/0003-4819-160-6-201403180-02009
ACP Journal Club |  18 March 2014
In AF or VTE, acenocoumarol or phenprocoumon dosing by genotype did not affect time in therapeutic range
Andrew Dunn, MD, SFHM, MPH, FACP
Ann Intern Med. 2014;160(6):JC10. doi:10.7326/0003-4819-160-6-201403180-02010
ACP Journal Club |  18 February 2014
Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation
Ignacio Neumann, MD, MSc; Romina Brignardello-Petersen, DDS, MSc; Gordon Guyatt, MD
Ann Intern Med. 2014;160(4):JC3. doi:10.7326/0003-4819-160-4-201402180-02003
ACP Journal Club |  18 February 2014
In out-of-hospital cardiac arrest, mechanical CPR did not improve survival compared with manual CPR
Eddy Lang, MD
Ann Intern Med. 2014;160(4):JC5. doi:10.7326/0003-4819-160-4-201402180-02005
ACP Journal Club |  17 December 2013
Review: In noncardiac surgery, β-blockers started before surgery increase 30-day mortality
Prashant Vaishnava, MD; Kim Eagle, MD, MACC
Ann Intern Med. 2013;159(12):JC2. doi:10.7326/0003-4819-159-12-201312170-02002
ACP Journal Club |  19 November 2013
Combined vasopressin, steroids, and epinephrine improved survival in in-hospital cardiac arrest
Kenneth A. Ballew, MD, MS
Ann Intern Med. 2013;159(10):JC4. doi:10.7326/0003-4819-159-10-201311190-02004
ACP Journal Club |  20 August 2013
Warfarin continuation was better than heparin bridging during pacemaker or ICD surgery
Thomas DeLoughery, MD, FACP, FAWM
Ann Intern Med. 2013;159(4):JC7. doi:10.7326/0003-4819-159-4-201308200-02007
ACP Journal Club |  16 July 2013
Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF
Sara Vazquez, PharmD; Matthew T. Rondina, MD
Ann Intern Med. 2013;159(2):JC8. doi:10.7326/0003-4819-159-2-201307160-02008
ACP Journal Club |  16 April 2013
Adding renal dysfunction to CHADS2 did not improve prediction of stroke or systemic embolism in AF
Catherine M. Clase, MD; Deborah L. Zimmerman, MD; Benjamin K. A. Thomson, MD
Ann Intern Med. 2013;158(8):JC13. doi:10.7326/0003-4819-158-8-201304160-02013
ACP Journal Club |  18 December 2012
Apixaban reduced stroke or systemic embolism more than warfarin in AF regardless of renal function
Melvyn M. Jones, MB, BS, MD, MRCGP
Ann Intern Med. 2012;157(12):JC6-7. doi:10.7326/0003-4819-157-12-201212180-02007
ACP Journal Club |  16 October 2012
Various risk stratification schemes predict ischemic stroke and bleeding in atrial fibrillation
Brian F. Gage, MD, MSc; Ambar Andrade, MD
Ann Intern Med. 2012;157(8):JC4-13. doi:10.7326/0003-4819-157-8-201210160-02013
ACP Journal Club |  18 September 2012
Review: New oral anticoagulants reduced stroke and systemic embolism compared with warfarin in AF
Liviu Klein, MD, MS
Ann Intern Med. 2012;157(6):JC3-2. doi:10.7326/0003-4819-157-6-201209180-02002
ACP Journal Club |  18 September 2012
Short-term was less effective than long-term flecainide for preventing recurrent AF after cardioversion
D. George Wyse, MD, PhD, FRCPC, FACP
Ann Intern Med. 2012;157(6):JC3-9. doi:10.7326/0003-4819-157-6-201209180-02009
ACP Journal Club |  17 January 2012
Apixaban reduced stroke and systemic embolism compared with warfarin in atrial fibrillation
Liviu Klein, MD, MS
Ann Intern Med. 2012;156(2):JC1-2. doi:10.7326/0003-4819-156-2-201201170-02002
ACP Journal Club |  17 January 2012
Rivaroxaban reduced stroke and systemic embolism compared with warfarin in nonvalvular AF
Liviu Klein, MD, MS
Ann Intern Med. 2012;156(2):JC1-3. doi:10.7326/0003-4819-156-2-201201170-02003
ACP Journal Club |  15 November 2011
A 5-item score predicted risk for warfarin-associated major hemorrhage in patients with atrial fibrillation
Nishant Nerella, MD
Ann Intern Med. 2011;155(10):JC5-13. doi:10.7326/0003-4819-155-10-201111150-02013
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)